SLNH vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

SLNH

41.1
AI Score
VS
SLNH Wins

HIVE

40.3
AI Score

Investment Advisor Scores

SLNH

41score
Recommendation
HOLD

HIVE

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SLNH HIVE Winner
Forward P/E 0 62.8931 Tie
PEG Ratio 0 0 Tie
Revenue Growth 144.6% 73.5% SLNH
Earnings Growth 0.0% -99.9% SLNH
Tradestie Score 41.1/100 40.3/100 SLNH
Profit Margin -182.2% -98.5% HIVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SLNH 1M: -0.9% · 3M: -16.4% HIVE 1M: +9.4% · 3M: -12.0%

Current Technical Phase

SLNH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 38

RSI (14): 38.4 · Price: $1.07

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46

RSI (14): 46.5 · Price: $2.98

Fundamentals Snapshot

Metric SLNH HIVE
Market Cap — —
Forward P/E -4.7 -5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.4% 0.7%
Gross Margin 0.6% 0.4%
Operating Margin -1.1% -0.6%
EPS -0.67 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SLNH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.